FDA Panel Recommends Emergency Use Authorization for Pfizer-BioNTech Vaccine in Children Ages 5-11

Strategic Insights -

A significant milestone in the fight against COVID-19 has been reached, as the Food and Drug Administration's panel of independent advisors has recommended emergency use authorization for the Pfizer-BioNTech vaccine in children aged 5 to 11. This decision, pending formal approval from the FDA, would allow for widespread vaccination of this age group, which has been disproportionately affected by the virus. The vaccine has shown 90.7% efficacy and safety in preventing COVID-19 in children 5 to 11, with observed side effects suggesting no safety concerns.

Key Takeaways:

  • The pediatric vaccine has one-third of the active ingredient compared to adult doses, chosen to "strike the right balance" between providing strong immunity and limiting side effects.
  • The vaccine formula is also made from a different substance to maintain stability, allowing it to be stored in a refrigerator for up to 10 weeks.
  • Distribution plans are in place, with 65 million doses already purchased and 28 million children aged 5 to 11 eligible for vaccination.
  • Pediatricians' offices, local pharmacies, and possibly schools will be ready to inject children on a wide scale, with over 25,000 providers signed on to provide COVID-19 vaccines.
  • Shipments of the vaccine will be in smaller packs of 100 doses each, making it easier for more providers to deliver them.
  • School- and community-based clinics will be funded and supported by the Federal Emergency Management Agency to get kids vaccinated quickly.
  • An education campaign about vaccine safety and ease is in the works.

Statistics:

  • 90.7% efficacy in preventing COVID-19 in children 5 to 11, as reported by Pfizer.
  • 28 million children aged 5 to 11 eligible for vaccination, according to the White House.
  • 65 million doses purchased, as reported by CBS News.
  • 10 weeks storage time at refrigerator temperature, as reported by NPR.
  • 40% of pediatric COVID-19 cases account for children 5 to 11 years old, as reported by Dr. Doran Fink.
  • 9% of reported overall COVID-19 cases in the U.S. account for children 5 to 11 years old, as reported by Dr. Doran Fink.
  • 1.9 million cases of COVID-19 reported in children 5 to 11 years old, as reported by the CDC.
  • Approximately 8,300 children hospitalized with COVID-19, as reported by the CDC.
  • About one-third of hospitalized children require treatment in the ICU, as reported by the CDC.
  • Children of color have been hospitalized at a rate three times higher than that of white children, as reported by the CDC.

Sources:

  • CBS News. 10/20/21
  • National Public Radio. 10/26/21